TIME SPENT ON WHAT MATTERS MOST
INVENTING
NEW
Teon’s goal is working to restore anti-tumor immunity with once-daily, oral cancer medications so that patients like Steve, a courageous fireman, can continue to spend time on what matters most.
Only 12% of patients with solid tumors are served by immunotherapy drugs available today.
We are inventing new hope for cancer patients by targeting untapped metabolic signaling pathways to restore anti-tumor immunity and provide better outcomes for patients.
We are inventing new hope for cancer patients by targeting untapped metabolic signaling pathways to restore anti-tumor immunity and provide better outcomes for patients.
Demonstrated Expertise
A powerhouse leadership team with a track record in oncology drug development and deep insights in G-protein coupled receptor (GPCR) signaling, small molecule design, along with a clear vision to push the boundaries of science in the immuno-oncology market.
Impeccable Science Addressing Untapped Pathways
Targeting unexploited metabolic pathways backed by validated science and an initial focus on maximizing the potential benefits of GPCRs to address difficult-to-treat cancers.
Impactful Value Drivers
Strong, focused clinical-stage pipeline of GPCR-directed therapies with first- and best-in-class candidates in oncology, targeting pathways that reverse immune cell suppression and halt tumor growth.
Time Spent on What Matters Most
Patients with cancer currently undergo lengthy infusions and spend precious time away from friends and family. Teon’s goal is to develop once-daily, oral medications to treat more patients and provide better outcomes allowing patients to spend time on what matters most.
Driven by Scientific Innovation and Unmet Need
Teon is designing novel therapies, building a focused pipeline and solving for significant unmet need in cancer care.
Transforming the Treatment Landscape
Our science backed by a track record of success and passion to deliver improved options for patients inspires our relentless pursuit of discovery and development.
Partnering to Improve Cancer Care
It takes collaboration to drive innovative treatments to transform lives. Partnerships with others who share our mission will help us reach more patients.
Careers
We work together as one integrated team and are committed to developing and delivering groundbreaking treatments for patients.
Press Releases
Stay updated on the latest news from Teon, including corporate and clinical announcements.
About Us
We are on a relentless mission to push the boundaries of science in cancer care as we know it.
Featured News
Read media coverage on Teon including insights from our executive leadership team.